Centre de Référence
des Maladies Autoinflammatoires
et des Amyloses

 
 
 
 
 
 

Publications

In press

Canakinumab treatment Real World Evidence in 3 monogenic Periodic Fever Syndromes in 2009-2022: an interim analysis using the French JIR cohort database
Isabelle Koné-Paut, Sophie Georgin-Lavialle, Alexandre Belot, Magali Jover, Mathilde Pouriel, Laure Lacoin, Pascal Pillet, Véronique Hentgen
ARTHRITIS RES THER - 2024

Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation
Camille Cosson, Romane Riou, Danish Patoli, Tingting Niu, Amaury Rey, Marine Groslambert, Elodie Chatre, Omran Allatif, Thomas Henry, Fabienne Venet, Florian Milhavet, Guilaine Boursier, Alexandre Belot, Yvan Jamilloux, Etienne Merlin, Agnes Duquesne, Gilles Grateau, Lea Savey, Alexandre Maria, Anne Pagnier, Solène Poutrel, Olivier Lambotte, Coralie Mallebranche, Frédéric Rieux-Laucat, Brigitte Bader-Meunier, Zahir Amoura, Isabelle Melki, Isabelle Touitou, Matthias Geyer, Sophie Georgin-lavialle, and Benedicte Py
J EXP MED - 2024

Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis
Hermine I. Brunner, Athimalaipet V. Ramanan, Gerd Horneff, Kirsten Minden, Inmaculada Calvo Penades,Ekaterina Alexeeva, Gavin Cleary, Sara Stern, Isabelle Kone-Paut, Maria del Rocio Maldonado Velasquez, Jonathan Akikusa, Mauro Zucchetto, Laura Brockwell, Oliver Gordon, Sandra Nagel, Nicolino Ruperto; Fabrizio De Benedetti,for the PRINTO and PRCSG investigators
RHEUMATOLOGY (Oxford) - 2024

Subcutaneous Anakinra in the management of refractory MIS-C in france
Perrine Dusser, Alexandre Belot, Fanny Bajolle, Anne PAGNIER, Ulrich Meinzer, Frédéric Huet, Soizic Tiriau and Isabelle Kone-paut
FRONT PEDIATR - 2024

Fièvre Méditerranéenne Familiale : nouveaux phénotypes et mécanismes génétiques
Martin Broly, Guilaine Boursier, Isabelle Touitou*
BULL ACAD NATL MED - 2023

Maladies auto-inflammatoires de l’enfant : apport de la génétique
Guilaine Boursier, Isabelle Touitou
REV PRAT - 2023

A comparative clinical trial to assess a standardized escalation dose strategy of interleukin-1 blockade in Kawasaki disease: The ANACOMP trial
Koné-Paut I, Toumazi A, Bourmaud A
CLIN INVESTIG (LOND) - 2021

 

2024 Voir une autre année ?